Idexx Laboratories (IDXX) Total Debt (2009 - 2026)

Idexx Laboratories (IDXX) has reported Total Debt for 18 consecutive years, with $829.9 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Total Debt rose 33.69% year-over-year to $829.9 million; the TTM figure through Mar 2026 stood at $829.9 million (up 33.69% YoY), while the FY2025 annual figure was $449.8 million, down 35.72% from the prior year.
• Total Debt came in at $829.9 million for Q1 2026 at Idexx Laboratories, up from $449.8 million in the prior quarter.
• The five-year high for Total Debt was $1.4 billion in Q3 2022, with the low at $449.8 million in Q4 2025.
• Average Total Debt over 5 years is $852.9 million, with a median of $829.8 million recorded in 2025.
• Across the five-year window, Total Debt jumped 63.4% in 2022 and tumbled 44.84% in 2023, its largest moves.
• Year by year, Total Debt stood at $944.4 million in 2022, then decreased by 26.1% to $697.9 million in 2023, then rose by 0.27% to $699.8 million in 2024, then plunged by 35.72% to $449.8 million in 2025, then surged by 84.48% to $829.9 million in 2026.
• According to Business Quant data, Total Debt over the past three periods registered $829.9 million, $449.8 million, and $829.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.